PARTI Overview We are a clinical-stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. We seek to utilize our teams deep drug development experience to maximize the potential of our lead product candidate, firmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, including ARR-217 (MRG007), through approval and ...
Q2 FY2026 — expected 2026-09-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-05 | 2025-12-31 | 0001104659-26-024127 | EDGAR | 116K words |
| 2025-03-03 | 2024-12-31 | 0001558370-25-001999 | EDGAR | — |
| 2024-03-28 | 2023-12-31 | 0001558370-24-004280 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-10 | 2025-09-30 | 0001104659-25-108847 | EDGAR | 20K words |
| 2025-08-11 | 2025-06-30 | 0001558370-25-010975 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001558370-25-007276 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001558370-24-015624 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001558370-24-012236 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0001558370-24-007197 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-17 | 0001104659-26-029588 | EDGAR | 1K words |
| 2026-03-05 | 0001104659-26-024112 | EDGAR | — |
| 2025-11-10 | 0001104659-25-108839 | EDGAR | — |
| 2025-09-09 | 0001558370-25-011954 | EDGAR | — |
| 2025-08-11 | 0001558370-25-010974 | EDGAR | — |
| 2025-07-21 | 0001104659-25-069169 | EDGAR | — |
| 2025-07-02 | 0001104659-25-065386 | EDGAR | — |
| 2025-06-23 | 0001104659-25-061375 | EDGAR | — |
| 2025-06-20 | 0001104659-25-061165 | EDGAR | — |
| 2025-05-12 | 0001558370-25-007259 | EDGAR | — |
40 total filings indexed. 21 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001868279 |
| Ticker | AVBP |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.arrivent.com |
| Listed | 2024-01-26 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/AVBP (~200 tokens, structured JSON with cryptographic provenance)